124 related articles for article (PubMed ID: 29973003)
1. [Association of plasma leptin levels and soluble leptin receptor with breast cancer].
Yi F; Diao S; Yuan XL; Li JY
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Mar; 52(3):253-259. PubMed ID: 29973003
[No Abstract] [Full Text] [Related]
2. [Population-based Study of the Effects of Adiponectin, Leptin and Soluble Leptin Receptor on Risks for Breast Cancer].
Yi F; Xu B; Diao S; Hou C; Li JY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Mar; 52(2):259-266. PubMed ID: 33829700
[TBL] [Abstract][Full Text] [Related]
3. Circulating leptin, soluble leptin receptor, free leptin index, visfatin and selected leptin and leptin receptor gene polymorphisms in sporadic breast cancer.
Rodrigo C; Tennekoon KH; Karunanayake EH; De Silva K; Amarasinghe I; Wijayasiri A
Endocr J; 2017 Apr; 64(4):393-401. PubMed ID: 28190851
[TBL] [Abstract][Full Text] [Related]
4. The relation of leptin and soluble leptin receptor levels with metabolic and clinical parameters in obese and healthy children.
Catli G; Anik A; Tuhan HÜ; Kume T; Bober E; Abaci A
Peptides; 2014 Jun; 56():72-6. PubMed ID: 24703965
[TBL] [Abstract][Full Text] [Related]
5. Plasma leptin levels and risk of breast cancer in premenopausal women.
Harris HR; Tworoger SS; Hankinson SE; Rosner BA; Michels KB
Cancer Prev Res (Phila); 2011 Sep; 4(9):1449-56. PubMed ID: 21680707
[TBL] [Abstract][Full Text] [Related]
6. Differential bone metabolism between postmenopausal women with osteoarthritis and osteoporosis.
Jiang LS; Zhang ZM; Jiang SD; Chen WH; Dai LY
J Bone Miner Res; 2008 Apr; 23(4):475-83. PubMed ID: 18052758
[TBL] [Abstract][Full Text] [Related]
7. Adipocytokines and breast cancer risk.
Hou WK; Xu YX; Yu T; Zhang L; Zhang WW; Fu CL; Sun Y; Wu Q; Chen L
Chin Med J (Engl); 2007 Sep; 120(18):1592-6. PubMed ID: 17908478
[TBL] [Abstract][Full Text] [Related]
8. Premenopausal levels of circulating insulin-like growth factor I and the risk of postmenopausal breast cancer.
Rollison DE; Newschaffer CJ; Tao Y; Pollak M; Helzlsouer KJ
Int J Cancer; 2006 Mar; 118(5):1279-84. PubMed ID: 16161053
[TBL] [Abstract][Full Text] [Related]
9. Leptin expression in breast nipple aspirate fluid (NAF) and serum is influenced by body mass index (BMI) but not by the presence of breast cancer.
Sauter ER; Garofalo C; Hewett J; Hewett JE; Morelli C; Surmacz E
Horm Metab Res; 2004 May; 36(5):336-40. PubMed ID: 15156414
[TBL] [Abstract][Full Text] [Related]
10. Plasma leptin levels and free leptin index in women with Alzheimer's disease.
Baranowska-Bik A; Bik W; Styczynska M; Chodakowska-Zebrowska M; Barcikowska M; Wolinska-Witort E; Kalisz M; Martynska L; Baranowska B
Neuropeptides; 2015 Aug; 52():73-8. PubMed ID: 26070219
[TBL] [Abstract][Full Text] [Related]
11. High expression of leptin receptor mRNA in breast cancer tissue predicts poor prognosis for patients with high, but not low, serum leptin levels.
Miyoshi Y; Funahashi T; Tanaka S; Taguchi T; Tamaki Y; Shimomura I; Noguchi S
Int J Cancer; 2006 Mar; 118(6):1414-9. PubMed ID: 16206269
[TBL] [Abstract][Full Text] [Related]
12. Changes in Body Mass Index, Leptin, and Leptin Receptor Polymorphisms and Breast Cancer Risk.
Liu CR; Li Q; Hou C; Li H; Shuai P; Zhao M; Zhong XR; Xu ZP; Li JY
DNA Cell Biol; 2018 Mar; 37(3):182-188. PubMed ID: 29336592
[TBL] [Abstract][Full Text] [Related]
13. Leptin and insulin growth factor I in relation to breast cancer (Greece).
Petridou E; Papadiamantis Y; Markopoulos C; Spanos E; Dessypris N; Trichopoulos D
Cancer Causes Control; 2000 May; 11(5):383-8. PubMed ID: 10877331
[TBL] [Abstract][Full Text] [Related]
14. Tracking of leptin, soluble leptin receptor, and the free leptin index during weight loss and regain in children.
Holm JC; Gamborg M; Ward LC; Gammeltoft S; Kaas-Ibsen K; Heitmann BL; Sørensen TI
Obes Facts; 2011; 4(6):461-8. PubMed ID: 22248997
[TBL] [Abstract][Full Text] [Related]
15. Leptin and leptin receptor genes in relation to premenopausal breast cancer incidence and grade in Caucasian women.
Gu F; Kraft P; Rice M; Michels KB
Breast Cancer Res Treat; 2012 Jan; 131(1):17-25. PubMed ID: 21947707
[TBL] [Abstract][Full Text] [Related]
16. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
[TBL] [Abstract][Full Text] [Related]
17. The roles of serum leptin concentration and polymorphism in leptin receptor gene at codon 109 in breast cancer.
Liu CL; Chang YC; Cheng SP; Chern SR; Yang TL; Lee JJ; Guo IC; Chen CP
Oncology; 2007; 72(1-2):75-81. PubMed ID: 18004080
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
Krajcik RA; Borofsky ND; Massardo S; Orentreich N
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
[TBL] [Abstract][Full Text] [Related]
19. The soluble leptin receptor of regular exercisers.
Tsao TH; Yang JB; Yang CB; Hsu CH; Liou TL
Int J Sports Med; 2007 Sep; 28(9):732-5. PubMed ID: 17525882
[TBL] [Abstract][Full Text] [Related]
20. Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study.
Abbas S; Chang-Claude J; Linseisen J
Int J Cancer; 2009 Jan; 124(1):250-5. PubMed ID: 18839430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
